p53: An Immune Ecosystem Manipulator

Area of Science:

• Oncology
• Immunology
• Cancer Genetics

Background:

• Mutations in p53 are frequent in cancer, leading to loss of its tumor-suppressive functions.
• p53 mutations significantly influence the tumor immune microenvironment, contributing to immunotherapy resistance.

Purpose of the Study:

• To elucidate the mechanisms by which p53 mutations establish an immune barrier network.
• To highlight the role of p53 as a mediator of immunotherapy resistance.

Main Methods:

• Review of existing literature on p53 mutations and their impact on the tumor immune microenvironment.
• Analysis of how p53 mutations modulate secretomes, immune ligands, antigen presentation, metabolism, and the extracellular matrix.

Main Results:

• p53 mutations create an
• immune barrier network
• ,
• This network involves modulation of cytokines, extracellular vesicles, immune ligands, antigen presentation, tumor metabolism, and the extracellular matrix.
• p53 mutations act as critical mediators of resistance to cancer immunotherapy.

Conclusions:

• Targeting the immune barrier network established by p53 mutations is a promising strategy for combination immunotherapy.
• Future research should investigate mutant p53 subtypes, organ specificity, and their dual role in neoantigen generation and immune suppression.